Helmut Wittkowski

8.2k total citations · 1 hit paper
90 papers, 3.9k citations indexed

About

Helmut Wittkowski is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Helmut Wittkowski has authored 90 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 45 papers in Immunology and 27 papers in Hematology. Recurrent topics in Helmut Wittkowski's work include Inflammasome and immune disorders (42 papers), Autoimmune and Inflammatory Disorders Research (24 papers) and S100 Proteins and Annexins (19 papers). Helmut Wittkowski is often cited by papers focused on Inflammasome and immune disorders (42 papers), Autoimmune and Inflammatory Disorders Research (24 papers) and S100 Proteins and Annexins (19 papers). Helmut Wittkowski collaborates with scholars based in Germany, United States and Netherlands. Helmut Wittkowski's co-authors include Dirk Foell, Johannes Roth, Thomas Vogl, Johannes Roth, Michael Frosch, Nico Wulffraat, Tilmann Kallinich, Christoph Kessel, Dorothee Viemann and Dirk Holzinger and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Helmut Wittkowski

83 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

2006 681 citations Dirk Foell, Helmut Wittkowski et al. profile →

Peers

Countries citing papers authored by Helmut Wittkowski

Since Specialization

Citations

This map shows the geographic impact of Helmut Wittkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmut Wittkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmut Wittkowski more than expected).

Fields of papers citing papers by Helmut Wittkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmut Wittkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmut Wittkowski. The network helps show where Helmut Wittkowski may publish in the future.

Co-authorship network of co-authors of Helmut Wittkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Helmut Wittkowski. A scholar is included among the top collaborators of Helmut Wittkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmut Wittkowski. Helmut Wittkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dysregulation of miRNA-30e-3p targeting IL-1β in an international cohort of systemic autoinflammatory disease patients 2023 ·Journal of Molecular Medicine ·(unknown), Yeliz Z. Akkaya‐Ulum, Ezgi Deniz Batu, Federica Penco, Helmut Wittkowski, (unknown), Mariëlle van Gijn, Dirk Foell, Marco Gattorno, Seza Özen, Banu Balcı‐Peynircioğlu	7
2	Inflammatory Biomarkers Can Differentiate Acute Lymphoblastic Leukemia with Arthropathy from Juvenile Idiopathic Arthritis Better Than Standard Blood Tests 2023 ·The Journal of Pediatrics ·(unknown), Mia Glerup, Dirk Foell, Christoph Kessel, Helmut Wittkowski, Lillemor Berntson, Anders Fasth, Susan Searles Nielsen, Ellen Nordal, Marite Rygg, Henrik Hasle, Troels Herlin	2
3	An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial 2022 ·Journal of Clinical Immunology ·Christoph Kessel, Isabelle Koné‐Paut, Stéphanie Tellier, Alexandre Bélot, Katja Masjosthusmann, Helmut Wittkowski, (unknown), Linda Rossi‐Semerano, Perrine Dusser, Isabelle Marié, (unknown), Hélène Agostini, Céline Piedvache, Dirk Foell	16
4	Cushing-Syndrom mit konsekutiver tertiärer Nebennierenrindeninsuffizienz nach simultaner multipler intraartikulärer Lokaltherapie mit Glukokortikoiden 2021 ·Zeitschrift für Rheumatologie ·Alexander Schramm, Daniel Windschall, Claas Hinze, (unknown), Helmut Wittkowski, (unknown), (unknown)	2
5	Increased Prevalence of NLRP3 Q703K Variant Among Patients With Autoinflammatory Diseases: An International Multicentric Study 2020 ·Frontiers in Immunology ·Katerina Theodoropoulou, Helmut Wittkowski, Nathalie Busso, Annette von Scheven-Gête, Isabelle Moix, Federica Vanoni, (unknown), Gerd Horneff, Johannes‐Peter Haas, Nadine Fischer, (unknown), Rainer Berendes, Georg Heubner, Annette Jansson, Elke Lainka, Annette Leimgruber, Michael A. Morris, Dirk Foell, Michaël Hofer	16
6	Das Still-Syndrom als biphasische Erkrankung 2020 ·Zeitschrift für Rheumatologie ·(unknown), Helmut Wittkowski, Claas Hinze	9
7	Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance 2019 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Dirk Holzinger, Toni Weinhage, Claas Hinze, Helmut Wittkowski, Peter Pickkers, Sabrin Albeituni, Katherine Verbist, Kim E. Nichols, Grant S. Schulert, Alexei A. Grom, Dirk Foell, Christoph Kessel	41
8	Proteomics in Chronic Arthritis—Will We Finally Have Useful Biomarkers? 2018 ·Current Rheumatology Reports ·Christoph Kessel, Angela McArdle, (unknown), Toni Weinhage, Helmut Wittkowski, Stephen R. Pennington, Dirk Foell	2
9	Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib 2017 ·International Immunopharmacology ·(unknown), Helmut Wittkowski, Aristotelis Antonopoulos, (unknown), Stuart M. Haslam, Dirk Föll, Anne Dell, Thorsten Marquardt	6
10	P Wave Dispersion and QT Dispersion in Adult Turkish Migrants with Familial Mediterranean Fever Living in Germany 2014 ·International Journal of Medical Sciences ·(unknown), (unknown), (unknown), Kaffer Kara, Helmut Wittkowski, Faekah Gohar, Bjoern A. Menge, Wolfgang E. Schmidt, (unknown)	7
11	Proinflammatory S100A12 Can Activate Human Monocytes via Toll-like Receptor 4 2013 ·American Journal of Respiratory and Critical Care Medicine ·Dirk Foell, Helmut Wittkowski, Christoph Kessel, (unknown), Toni Weinhage, Georg Varga, Thomas Vogl, Timo Wirth, Dorothee Viemann, Per Björk, Marieke A. D. van Zoelen, Faekah Gohar, Geetha Srikrishna, Matthias Kraft, Johannes Roth	140
12	Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12 2013 ·Inflammatory Bowel Diseases ·Jan Däbritz, Jost Langhorst, Andreas Lügering, Jan Heidemann, (unknown), Helmut Wittkowski, Thomas Krummenerl, Dirk Foell	61
13	The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis 2012 ·Annals of the Rheumatic Diseases ·Dirk Holzinger, Michael Frosch, (unknown), Femke H. M. Prince, M.H. Otten, Lisette W. A. van Suijlekom‐Smit, R. ten Cate, Esther P A H Hoppenreijs, Sandra Hansmann, Halima Moncrieffe, Simona Ursu, Lucy R. Wedderburn, Johannes Roth, Dirk Foell, Helmut Wittkowski	117
14	MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes 2011 ·Annals of the Rheumatic Diseases ·Helmut Wittkowski, J. B. Kuemmerle‐Deschner, Judith Austermann, Dirk Holzinger, Raphaela Goldbach‐Mansky, (unknown), P Lohse, Thomas Jung, Johannes Roth, Susanne M. Benseler, (unknown)	45
15	Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome 2010 ·Arthritis & Rheumatism ·Jasmin Kuemmerle‐Deschner, Pascal N. Tyrrell, I. Koetter, Helmut Wittkowski, Anja Bialkowski, (unknown), Peter Lohse, (unknown), Christoph Deuter, Dirk Foell, Susanne M. Benseler	129
16	Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function 2009 ·BMC Biochemistry ·Olga V. Moroz, (unknown), Helmut Wittkowski, Wei He, Anatoli Ianoul, Vera Novitskaya, Jingjing Xie, Oxana Polyakova, Igor K. Lednev, Alexander Shekhtman, Peter J. Derrick, (unknown), Dirk Foell, Igor Bronstein	97
17	The myeloid‐related proteins 8 and 14 complex, a novel ligand of toll‐like receptor 4, and interleukin‐1β form a positive feedback mechanism in systemic‐onset juvenile idiopathic arthritis 2009 ·Arthritis & Rheumatism ·Michael Frosch, Martina Ahlmann, Thomas Vogl, Helmut Wittkowski, Nico Wulffraat, Dirk Foell, Johannes Roth	129
18	Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome 2007 ·Critical Care Medicine ·Helmut Wittkowski, Anne Sturrock, Marieke A. D. van Zoelen, Dorothee Viemann, Tom van der Poll, John R. Hoidal, Johannes Roth, Dirk Foell	100
19	S100A12-expression is upregulated by TNF and may serve as a marker for the success of anti-TNF therapy 2005 ·Ghent University Academic Bibliography (Ghent University) ·Helmut Wittkowski, A-K Ulfgren, Leen De Rycke, Filip De Keyser, Lars Klareskog, Jürgen Röth, Dirk Foell	1
20	Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations 2004 ·Arthritis & Rheumatism ·Dirk Foell, Helmut Wittkowski, (unknown), Nico Wulffraat, Heinrike Schmeling, Michael Frosch, Gerd Horneff, Wietse Kuis, Clemens Sorg, Johannes Roth	126

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact